Connecticut's Psychedelic Treatment Program; US Senators Press NIH/FDA for Psychedelic Plans; Phase II results of LSD for Anxiety
www.thetripreport.com
This week reinvigorated my conviction that this whole psychedelic thing is the most fascinating and stimulating domain to pay attention to and be involved with. When we talk about “psychedelics” as an industry, a social movement, a field of study, an area of interest—whatever you want to call it—it is unique in that it is the intersection of many domains, each distinct, complex, and engaging in their own right:
Connecticut's Psychedelic Treatment Program; US Senators Press NIH/FDA for Psychedelic Plans; Phase II results of LSD for Anxiety
Connecticut's Psychedelic Treatment Program…
Connecticut's Psychedelic Treatment Program; US Senators Press NIH/FDA for Psychedelic Plans; Phase II results of LSD for Anxiety
This week reinvigorated my conviction that this whole psychedelic thing is the most fascinating and stimulating domain to pay attention to and be involved with. When we talk about “psychedelics” as an industry, a social movement, a field of study, an area of interest—whatever you want to call it—it is unique in that it is the intersection of many domains, each distinct, complex, and engaging in their own right: